Literature DB >> 29605290

Responses in patients receiving sequential paclitaxel post progression on PD1 inhibitors.

Ammar Sukari1, Misako Nagasaka2, Nadine Abdallah3.   

Abstract

This report describes highlights the dramatic responses seen in patients who were given paclitaxel post progression on immunotherapy. There are multiple mechanisms by which synergistic effects of immunotherapy and chemotherapy occur. Further prospective studies on chemotherapy and immunotherapy are eagerly awaited.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chemoimmunotherapy; Head and neck squamous cell carcinoma; Pembrolizumab; Synergy; Taxanes

Year:  2018        PMID: 29605290     DOI: 10.1016/j.oraloncology.2018.03.011

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  1 in total

1.  Cetuximab and methotrexate in recurrent or metastatic head and neck squamous cell carcinoma-A single institution analysis of 54 patients.

Authors:  Ammar Sukari; Misako Nagasaka; Maria Diab; Khaled Al Sibai; Bassel Atassi; Jailan A Elayoubi; Seongho Kim; Ömer Küçük
Journal:  Clin Otolaryngol       Date:  2019-04-01       Impact factor: 2.597

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.